Targeting ubiquitin-activating enzyme induces ER stress–mediated apoptosis in B-cell lymphoma cells

作者
Scott Best,Taylor Hashiguchi,Adam S. Kittai,Nur Bruss,Cody J. Paiva,Craig Y. Okada,Tingting Liu,Allison Berger,Alexey Valeryevich Danilov
出处
期刊:Blood Advances [Elsevier BV]
卷期号:3 (1): 51-62 被引量:51
标识
DOI:10.1182/bloodadvances.2018026880
摘要

Alterations in the ubiquitin proteasome system (UPS) leave malignant cells in heightened cellular stress, making them susceptible to proteasome inhibition. However, given the limited efficacy of proteasome inhibitors in non-Hodgkin lymphoma (NHL), novel approaches to target the UPS are needed. Here, we show that TAK-243, the first small-molecule inhibitor of the ubiquitin activating enzyme (UAE) to enter clinical development, disrupts all ubiquitin signaling and global protein ubiquitination in diffuse large B-cell lymphoma (DLBCL) cells, thereby inducing endoplasmic reticulum (ER) stress and the unfolded protein response (UPR). Activation of the ER stress response protein kinase R (PKR)-like ER kinase and phosphorylation of eukaryotic translation initiator factor 2α led to upregulation of the proapoptotic molecule C/EBP homologous protein and cell death across a panel of DLBCL cell lines independent of cell of origin. Concurrently, targeting UAE led to accumulation of Cdt1, a replication licensing factor, leading to DNA rereplication, checkpoint activation, and cell cycle arrest. MYC oncoprotein sensitized DLBCL cells to UAE inhibition; engineered expression of MYC enhanced while genetic MYC knockdown protected from TAK-243-induced apoptosis. UAE inhibition demonstrated enhanced ER stress and UPR and increased potency compared with bortezomib in DLBCL cell lines. In vivo treatment with TAK-243 restricted the growth of xenografted DLBCL tumors, accompanied by reduced cell proliferation and apoptosis. Finally, primary patient-derived DLBCL cells, including those expressing aberrant MYC, demonstrated susceptibility to UAE inhibition. In sum, targeting UAE may hold promise as a novel therapeutic approach in NHL.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
reiner完成签到 ,获得积分10
刚刚
刚刚
刚刚
耶耶完成签到 ,获得积分10
1秒前
1秒前
研友_VZG7GZ的应助被daihq3采纳,获得10
1秒前
1秒前
二二的叶之梦完成签到,获得积分10
1秒前
iinni完成签到 ,获得积分10
1秒前
Ximilu完成签到 ,获得积分10
1秒前
1秒前
wt完成签到,获得积分10
1秒前
1秒前
tttt关注了科研通微信公众号
1秒前
无花果的应助被wzy采纳,获得10
2秒前
小晏完成签到,获得积分10
2秒前
3秒前
3秒前
觞酌完成签到,获得积分10
3秒前
3秒前
彭于晏的应助被随心采纳,获得10
3秒前
异乡人完成签到,获得积分10
4秒前
细腻的海露完成签到,获得积分10
4秒前
4秒前
ss完成签到,获得积分10
4秒前
孙大伟发布了新的文献求助10
4秒前
英俊的铭的应助被37采纳,获得10
5秒前
自觉的断缘完成签到,获得积分10
5秒前
英吉利25发布了新的文献求助10
5秒前
科研通AI2S的应助被siquan采纳,获得10
5秒前
JamesPei的应助被肖馨余采纳,获得10
5秒前
Mina完成签到 ,获得积分10
6秒前
哦哦哦发布了新的文献求助10
6秒前
CipherSage的应助被其实我是橙色采纳,获得10
6秒前
6秒前
蜜蜂发布了新的文献求助10
6秒前
7秒前
fanfan完成签到,获得积分10
7秒前
Nole的应助被GIK尘采纳,获得30
7秒前
老乔发布了新的文献求助10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180757
求助须知:如何正确求助?哪些是违规求助? 9570857
关于积分的说明 21814590
捐赠科研通 7777053
什么是DOI,文献DOI怎么找? 3433314
关于科研通互助平台的介绍 2557579
邀请新用户注册赠送积分活动 2479315